Skip to content

Effect of Guduchyadi kwath syrup in Common cold in children

A comparative clinical study to evaluate the role of Guduchyadi kwath syrup in Pratishyaya w.s.r. to Common cold in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031431
Enrollment
40
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Guduchyadi kwath syrup: Syrup comprising kwath made up of guduchi, nimba, dhaniya, shunthi, raktachandan, musta and madhu Dose 1ml/kg body weight in 3 divided doses Oral Route of admini

Sponsors

Dr Mahesh Narayan Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having allergic history. Patients who fulfill diagnostic criteria of Pratishyaya.

Exclusion criteria

Exclusion criteria: Patients below 2.00 years and above 10.00 years. Congenital defects and disorders. Patients having severe cardiovascular, gastrointestinal and renal disease. Hematological, neurological and psychiatric disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be assessed on the basis of improvement in the symptoms of Pratishyaya as cough, fever, post nasal discharge, nasal blockage, sneezing, nasal itching, running nose, headache, dryness of throat, pricking pain in temporal region, hoarseness of voice etc. The patients will be observed for both subjective and objective parameters (or as per requirement) on 7th day and 15th day during the trial. Another follow up will be done 15 days after completion of trial.Timepoint: The primary outcome will be assessed on the basis of improvement in the symptoms of Pratishyaya as cough, fever, post nasal discharge, nasal blockage, sneezing, nasal itching, running nose, headache, dryness of throat, pricking pain in temporal region, hoarseness of voice etc. The patients will be observed for both subjective and objective parameters (or as per requirement) on 7th day and 15th day during the trial. Another follow up will be done 15 days after completion of trial.

Secondary

MeasureTime frame
OBJECTIVE CRITERIA- The effect of medicine will also be analyzed on following parameters before and after treatment. â?¢ Hb%, TLC, DLC, ESR, AEC OVERALL EFFECT OF THERAPY- The total effect of therapy of this trial will be grouped as follow- 1. Complete remission - 100% 2. Markedly improvement - 75 -100% 3. Moderate improvement - 50 -75% 4. Mild improvement - 25 -50% 5. No improvement - 0 -25 %Timepoint: First follow up at 7th day and 2nd follow up at 15th day. OBJECTIVE CRITERIA- The effect of medicine will also be analyzed on following parameters before and after treatment. â?¢ Hb%, TLC, DLC, ESR, AEC OVERALL EFFECT OF THERAPY- The total effect of therapy of this trial will be grouped as follow- 1. Complete remission - 100% 2. Markedly improvement - 75 -100% 3. Moderate improvement - 50 -75% 4. Mild improvement - 25 -50% 5. No improvement - 0 -25 %

Countries

India

Contacts

Public ContactDr Sneha Tripathi

State Ayurvedic College, Lucknow

mngupta75@yahoo.com9415447523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026